Your browser doesn't support javascript.
loading
Diffusion-Weighted Imaging, MR Angiography, and Baseline Data in a Systematic Multicenter Analysis of 3,301 MRI Scans of Ischemic Stroke Patients-Neuroradiological Review Within the MRI-GENIE Study.
Drake, Mattias; Frid, Petrea; Hansen, Björn M; Wu, Ona; Giese, Anne-Katrin; Schirmer, Markus D; Donahue, Kathleen; Cloonan, Lisa; Irie, Robert E; Bouts, Mark J R J; McIntosh, Elissa C; Mocking, Steven J T; Dalca, Adrian V; Sridharan, Ramesh; Xu, Huichun; Giralt-Steinhauer, Eva; Holmegaard, Lukas; Jood, Katarina; Roquer, Jaume; Cole, John W; McArdle, Patrick F; Broderick, Joseph P; Jiménez-Conde, Jordi; Jern, Christina; Kissela, Brett M; Kleindorfer, Dawn O; Lemmens, Robin; Meschia, James F; Rundek, Tatjana; Sacco, Ralph L; Schmidt, Reinhold; Sharma, Pankaj; Slowik, Agnieszka; Thijs, Vincent; Woo, Daniel; Worrall, Bradford B; Kittner, Steven J; Mitchell, Braxton D; Rosand, Jonathan; Golland, Polina; Lindgren, Arne; Rost, Natalia S; Wassélius, Johan.
Afiliación
  • Drake M; Department of Clinical Sciences Lund, Radiology, Lund University, Lund, Sweden.
  • Frid P; Department of Radiology, Neuroradiology, Skåne University Hospital, Lund, Sweden.
  • Hansen BM; Department of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden.
  • Wu O; Department of Neurology and Rehabilitation Medicine, Neurology, Skåne University Hospital, Malmö, Sweden.
  • Giese AK; Department of Clinical Sciences Lund, Radiology, Lund University, Lund, Sweden.
  • Schirmer MD; Department of Radiology, Neuroradiology, Skåne University Hospital, Lund, Sweden.
  • Donahue K; Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital (MGH), Harvard Medical School, Charlestown, MA, United States.
  • Cloonan L; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
  • Irie RE; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, United States.
  • Bouts MJRJ; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
  • McIntosh EC; Department of Population Health Sciences, German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Mocking SJT; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
  • Dalca AV; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
  • Sridharan R; Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital (MGH), Harvard Medical School, Charlestown, MA, United States.
  • Xu H; Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital (MGH), Harvard Medical School, Charlestown, MA, United States.
  • Giralt-Steinhauer E; Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital (MGH), Harvard Medical School, Charlestown, MA, United States.
  • Holmegaard L; Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital (MGH), Harvard Medical School, Charlestown, MA, United States.
  • Jood K; Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital (MGH), Harvard Medical School, Charlestown, MA, United States.
  • Roquer J; Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, United States.
  • Cole JW; Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge, MA, United States.
  • McArdle PF; Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.
  • Broderick JP; Department of Neurology, Neurovascular Research Group (NEUVAS), IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), University at Autonoma de Barcelona, Barcelona, Spain.
  • Jiménez-Conde J; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Jern C; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Kissela BM; Department of Neurology, Neurovascular Research Group (NEUVAS), IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), University at Autonoma de Barcelona, Barcelona, Spain.
  • Kleindorfer DO; Department of Neurology, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore, MD, United States.
  • Lemmens R; Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.
  • Meschia JF; Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
  • Rundek T; Department of Neurology, Neurovascular Research Group (NEUVAS), IMIM-Hospital del Mar (Institut Hospital del Mar d'Investigacions Mèdiques), University at Autonoma de Barcelona, Barcelona, Spain.
  • Sacco RL; Department of Laboratory Medicine, Institute of Biomedicine, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Schmidt R; Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
  • Sharma P; Department of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
  • Slowik A; Department of Neurosciences, Experimental Neurology and Leuven Research Institute for Neuroscience and Disease (LIND), Leuven, Belgium.
  • Thijs V; Department of Neurology, VIB, Vesalius Research Center, Laboratory of Neurobiology, University Hospitals Leuven, Leuven, Belgium.
  • Woo D; Department of Neurology, Mayo Clinic, Jacksonville, FL, United States.
  • Worrall BB; Department of Neurology and the Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL, United States.
  • Kittner SJ; Department of Neurology and the Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL, United States.
  • Mitchell BD; Clinical Division of Neurogeriatrics, Department of Neurology, Medical University Graz, Graz, Austria.
  • Rosand J; Institute of Cardiovascular Research, Royal Holloway University of London (ICR2UL), Egham, United Kingdom.
  • Golland P; Ashford and St Peter's Hospital, Surrey, United Kingdom.
  • Lindgren A; Department of Neurology, Jagiellonian University Medical College, Krakow, Poland.
  • Rost NS; Stroke Division, Florey Institute of Neuroscience and Mental Health, Heidelberg, VIC, Australia.
  • Wassélius J; Department of Neurology, Austin Health, Heidelberg, VIC, Australia.
Front Neurol ; 11: 577, 2020.
Article en En | MEDLINE | ID: mdl-32670186
ABSTRACT

Background:

Magnetic resonance imaging (MRI) serves as a cornerstone in defining stroke phenotype and etiological subtype through examination of ischemic stroke lesion appearance and is therefore an essential tool in linking genetic traits and stroke. Building on baseline MRI examinations from the centralized and structured radiological assessments of ischemic stroke patients in the Stroke Genetics Network, the results of the MRI-Genetics Interface Exploration (MRI-GENIE) study are described in this work.

Methods:

The MRI-GENIE study included patients with symptoms caused by ischemic stroke (N = 3,301) from 12 international centers. We established and used a structured reporting protocol for all assessments. Two neuroradiologists, using a blinded evaluation protocol, independently reviewed the baseline diffusion-weighted images (DWIs) and magnetic resonance angiography images to determine acute lesion and vascular occlusion characteristics.

Results:

In this systematic multicenter radiological analysis of clinical MRI from 3,301 acute ischemic stroke patients according to a structured prespecified protocol, we identified that anterior circulation infarcts were most prevalent (67.4%), that infarcts in the middle cerebral artery (MCA) territory were the most common, and that the majority of large artery occlusions 0 to 48 h from ictus were in the MCA territory. Multiple acute lesions in one or several vascular territories were common (11%). Of 2,238 patients with unilateral DWI lesions, 52.6% had left-sided infarct lateralization (P = 0.013 for χ2 test).

Conclusions:

This large-scale analysis of a multicenter MRI-based cohort of AIS patients presents a unique imaging framework facilitating the relationship between imaging and genetics for advancing the knowledge of genetic traits linked to ischemic stroke.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Neurol Año: 2020 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Neurol Año: 2020 Tipo del documento: Article País de afiliación: Suecia